From Psychedelic Pharma To Crop Gene Editing - The UK’s Big Opportunity Psychedelic drug discovery is generating a buzz throughout the scientific community in the UK. 

Where barriers once were, the recently presented Gene Technology Bill opens doors to the likes of crop gene editing to pharma companies who support the legislative framework.